Kronos Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Kronos Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Kronos Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000.
  • Kronos Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $567K, a 33.4% decline from 2022.
  • Kronos Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $851K, a 80.9% decline from 2021.
  • Kronos Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $4.46M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $567K -$284K -33.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $851K -$3.61M -80.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $4.46M -$411M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $416M* +$311M Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $105M +$88.8M +547% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $16.2M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.